-
1
Somatic mutations and DNA methylation identify a subgroup of poor prognosis within lower‐risk myelodysplastic syndromes
Published 2025-01-01“…HemaSphere…”
Get full text
Article -
2
Disease characteristics and outcomes of acute myeloid leukemia in germline RUNX1 deficiency (Familial Platelet Disorder with associated Myeloid Malignancy)
Published 2025-01-01“…HemaSphere…”
Get full text
Article -
3
Delving deeper into the pathogenesis and genomics of posttransplant diffuse large B‐cell lymphoma
Published 2025-04-01“…HemaSphere…”
Get full text
Article -
4
NK‐type large granular lymphocyte leukemia comes of age
Published 2025-06-01“…HemaSphere…”
Get full text
Article -
5
Distribution reappraisal of peripheral T‐ and NK‐cell lymphoma entities through the French Lymphopath network database
Published 2025-07-01“…HemaSphere…”
Get full text
Article -
6
Combining SKY92 gene expression profiling and FISH (according to R2‐ISS) defines ultra‐high‐risk Multiple Myeloma
Published 2025-01-01“…HemaSphere…”
Get full text
Article -
7
Who owns that blood? Recontacting donors with results from genetic testing after allogeneic hematopoietic cell transplantation
Published 2025-03-01“…HemaSphere…”
Get full text
Article -
8
Postoperative stage 0 Hodgkin lymphoma. Is surgery alone a curative option?
Published 2025-01-01“…HemaSphere…”
Get full text
Article -
9
Validation of the diagnostic potential of 17 immunophenotypic core markers defined by the ELN‐iMDS‐Flow Working Group in an independent cohort of patients with MDS
Published 2025-03-01“…HemaSphere…”
Get full text
Article -
10
-
11
Replacement therapy in pregnant women with von Willebrand disease during delivery: Factor levels and pharmacokinetics
Published 2025-01-01“…HemaSphere…”
Get full text
Article -
12
Luspatercept versus mitapivat for non‐transfusion‐dependent β‐thalassemia: Dare to compare?
Published 2025-07-01“…HemaSphere…”
Get full text
Article -
13
Secondary lesions and sensitivity to signaling inhibitors in iAMP21 acute lymphoblastic leukemia
Published 2025-01-01“…HemaSphere…”
Get full text
Article -
14
Impact of myelodysplasia‐related and additional gene mutations in intensively treated patients with NPM1‐mutated AML
Published 2025-01-01“…HemaSphere…”
Get full text
Article -
15
-
16
Idecabtagene vicleucel or ciltacabtagene autoleucel for relapsed or refractory multiple myeloma: An international multicenter study
Published 2025-01-01“…HemaSphere…”
Get full text
Article -
17
Prognostic significance of immune reconstitution following CD19 CAR T‐cell therapy for relapsed/refractory B‐cell lymphoma
Published 2025-01-01“…HemaSphere…”
Get full text
Article -
18
-
19
-
20